CD8A and breast neoplasm: The original data is composed of T lymphocytes extracted from a human breast tumor, sorted by flow cytometry into CD8 T cells and activated regulatory T cells and processed following the SmartSeq2 protocol (Picelli et al., 2014) (see details in Supplementary Material).